| Financial Year |
March 31 2023 |
| Monetary Funds |
1,078,738,843.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
473,150.00 |
| Accounts Receivable |
1,022,567,644.46 |
| Advances to Suppliers |
107,798,916.77 |
| Other Receivables |
84,943,827.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
672,270,038.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
73,961,504.69 |
| Total Current Assets |
3,556,377,866.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
33,177,163.42 |
| Long-term Equity Investment |
53,429,215.66 |
| Investment Properties |
-- |
| Fixed Assetes |
415,588,398.09 |
| Under-construction Projects |
1,227,712.37 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
254,217,271.69 |
| R&D expenses |
121,508,911.16 |
| Goodwill |
542,202,213.88 |
| Long-Term Deferred and Prepaid Expenses |
31,935,189.89 |
| Deferred Income Tax Assets |
99,050,693.69 |
| Other Non-Current Assets |
59,191,540.83 |
| Sub-Total of Non-Current Assets |
2,035,662,050.16 |
| Total Assets |
5,592,039,916.37 |
| Short-Term Loans |
286,039,393.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,146,891.00 |
| Accounts Payable |
438,717,801.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
51,040,572.25 |
| Taxes Payable |
7,810,858.10 |
| Interest Payable |
-- |
| Dividend Payable |
200,000.00 |
| Other payables |
19,357,288.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
20,476,318.31 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,226,623,464.42 |
| Long-term Loans |
50,197,222.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,514,356.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
213,757,724.26 |
| Total Liabilities |
1,440,381,188.68 |
| Paid-In Capital(Or Share Stock) |
859,477,310.00 |
| Capital Surplus |
1,337,297,403.55 |
| Surplus Reserve |
168,129,934.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,565,395,119.36 |
| Minority Stockholder's Interest |
88,227,826.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,063,430,901.38 |
| Owner's Equity（Stockholder's Equity） |
4,151,658,727.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,592,039,916.37 |
